Biochemical mechanisms of hibernation and stunning in the human heart

Cardiovascular Research

Volumn 56, Issue 3, 2002, Pages 411-421

  Lüss, Hartmut ^a   Schäfers, Michael ^a   Neumann, Joachim ^a   Hammel, Dieter ^a   Vahlhaus, Christian ^a   Baba, Hideo A ^b   Janssen, Frauke ^a   Scheld, Hans H ^a   Schober, Otmar ^a   Breithardt, Günter ^a   Schmitz, Wilhelm ^a   Wichter, Thomas ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Calcium (cellular); Contractile function; Hibernation; Ischemia; Stunning

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALSEQUESTRIN; CYCLIC AMP; HEAT SHOCK PROTEIN 72; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLAMBAN; TROPONIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE BIOPSY; HEART VENTRICULOGRAPHY; HUMAN; HUMAN TISSUE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CALCIUM; CORONARY ARTERY BYPASS; CORONARY CIRCULATION; CYCLIC AMP; FEMALE; HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL STUNNING; MYOCARDIUM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036890544     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00596-5     Document Type: Article

References (43)

1. Canty J.M. Jr., Fallavollita J.A. Chronic hibernation and chronic stunning: a continuum. J Nucl Cardiol. 7:2000;509-527.
2. Bolli R., Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 79:1999;609-634.
3. Frass O., Sharma H.S., Knoll R., et al. Enhanced gene expression of calcium regulatory proteins in stunned porcine myocardium. Cardiovasc Res. 27:1993;2037-2043.
4. Deindl E., Neubauer E., Elsasser A., et al. Reduced contractile function characteristic of hibernating human heart is not mediated by phospholamban. Ann NY Acad Sci. 853:1998;270-272.
5. Fallavollita J.A., Jacob S., Young R., et al. Regional alterations in SR Ca(2+)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol. 277:1999;H1418-1428.
6. Lüss H., Bokník P., Heusch G., et al. Expression of calcium regulatory proteins in short-term hibernation and stunning in the in situ porcine heart. Cardiovasc Res. 37:1998;606-617.
7. Thomas S.A., Fallavollita J.A., Lee T.C., et al. Absence of troponin I degradation or altered sarcoplasmic reticulum uptake protein expression after reversible ischemia in swine. Circ Res. 85:1999;446-456.
8. Lüss H., Meissner A., Rolf N., et al. On the biochemical mechanisms of stunning in the conscious dog. Am J Physiol. 279:2000;H176-H184.
9. Meissner A., Lüss I., Rolf N., et al. The early response genes c-jun and HSP-70 are induced in regional cardiac stunning in conscious mammals. J Thorac Cardiovasc Surg. 119:2000;820-825.
10. Lüss H., Neumann J., Schmitz W., et al. The stress-responsive MAP kinase p38 is activated by low-flow ischemia in the in situ porcine heart. J Mol Cell Cardiol. 32:2000;1787-1794.
11. Shan K., Bick R.J., Poindexter B.J., et al. Altered adrenergic receptor density in myocardial hibernation in humans: a possible mechanism of depressed myocardial function. Circulation. 102:2000;2599-2606.
12. Kadambi V.J., Ponniah S., Harrer J., et al. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest. 97:1996;533-539.
13. 2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin. J Clin Invest. 101:1998;1385-1393.
14. Periasamy M., Reed T.D., Liu L.H., et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca2+-ATPase isoform 2 (SERCA2) gene. J Biol Chem. 274:1999;2556-2562.
15. Huang X., Pi Y., Lee K.J., et al. Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. Circ Res. 84:1999;1-8.
16. Houser S.R., Piacentino V. III, Weisser J. Abnormalities of calcium cycling in the hypertrophied and failing heart. J Mol Cell Cardiol. 32:2000;1595-1607.
17. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237:1979;E214-223.
18. Knuuti M.J., Nuutila P., Ruotsalainen U., et al. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med. 33:1992;1255-1262.
19. Patlak C.S., Blasberg R.G. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab. 5:1985;584-590.
20. Gambhir S.S., Schwaiger M., Huang S.C., et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med. 30:1989;359-366.
21. Pietrzyk U., Herholz K., Heiss W.D. Three-dimensional alignment of functional and morphological tomograms. J Comp Assist Tomogr. 14:1990;51-59.
22. Pietrzyk U., Herholz K., Fink G., et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med. 35:1994;2011-2018.
23. Biedenstein S., Schäfers M., Stegger L., et al. Three-dimensional contour of left ventricular myocardium using elastic surfaces. Eur J Nucl Med. 26:1999;201-207.
24. Stegger L., Biedenstein S., Schäfers K.P., et al. Elastic surface contour detection for the measurement of ejection fraction in myocardial perfusion SPET. Eur J Nucl Med. 28:2001;48-55.
25. vom Dahl J., Altehoefer C., Sheehan F.H., et al. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease. J Nucl Med. 38:1997;742-748.
26. Port J.D., Bristow M.R. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol. 33:2001;887-905.
27. Chakraborti S., Chakraborti T., Shaw G. Beta-adrenergic mechanisms in cardiac diseases: a perspective. Cell Signal. 12:2000;499-513.
28. Danielsen W., v der Leyen H., Meyer W., et al. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharmacol. 14:1989;171-173.
29. Ungerer M., Weig H.J., Kubert S., et al. Regional pre- and postsynaptic sympathetic system in the failing human heart-regulation of beta ARK-1. Eur J Heart Fail. 2:2000;23-31.
30. Sunahara R.K., Dessauer C.W., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu Rev Pharmacol Toxicol. 36:1996;461-480.
31. Senzaki H., Smith C.J., Juang G.J., et al. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure. FASEB J. 15:2001;1718-1726.
32. Neumann J., Boknik P., DePauliRoach, et al. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility. J Mol Cell Cardiol. 30:1998;1991-2002.
33. Völler H., Nixdorff U., Flachskampf F.A. Myokardialer Vitalitätsnachweis mit der Dobutamin-Echokardiografie: Aktuelle Übersicht. Z Kardiol. 89:2000;921-931.
34. Westfall M.V., Solaro R.J. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res. 70:1992;302-313.
35. Gao W.D., Atar D., Liu Y., et al. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. 80:1997;393-399.
36. Schulz R., Post H., Neumann T., et al. Progressive loss of perfusion-contraction matching during sustained moderate ischemia in pigs. Am J Physiol. 280:2001;H1945-1953.
37. Trost S.U., Omens J.H., Karlon W.J., et al. Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70. J Clin Invest. 101:1998;855-862.
38. Nishizawa J., Nakai A., Higashi T., et al. Reperfusion causes significant activation of heat shock transcription factor 1 in ischemic rat heart. Circulation. 94:1996;2185-2192.
39. Taggart D.P., Bakkenist C.J., Biddolph S.C., et al. Induction of myocardial heat shock protein 70 during cardiac surgery. J Pathol. 182:1997;362-366.
40. Gray C.C., Amrani M., Yacoub M.H. Heat stress proteins and myocardial protection: experimental model or potential clinical tool? Int J Biochem Cell Biol. 31:1999;559-573.
41. Cook S.A., Sugden P.H., Clerk A. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease. J Mol Cell Cardiol. 31:1999;1429-1434.
42. Wijns W., Vatner S.F., Camici P.G. Hibernating myocardium. N Engl J Med. 339:1998;173-181.
43. Canty J.M. Jr., Fallavollita J.A. Resting myocardial flow in hibernating myocardium: validating animal models of human pathophysiology. Am J Physiol. 277:1999;H417-422.